Komori
Earnings7780Menicon Co.,Ltd.Electrical Equipment and Precision Instruments

Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)

In the first quarter, sales of daily disposable contact lenses in Japan and overseas and the MELS Plan increased, driving a 7.0% year-on-year increase in net sales. Operating profit also rose 74.9% due to higher gross profit and a review of the cost structure for selling, general and administrative expenses. Ordinary profit and net profit increased further, helped by foreign exchange gains.

Worth reading
49Recurring
Scored from 5 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
74.9
% (year-on-year increase in operating profit)
Wording
Conditional
How definitive the wording is.

Results for this period

First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAP
Net Sales32,376million yenYear on year +7.0%Progress 24.3%
Operating profit3,429million yenYear on year +74.9%Progress 31.2%
Ordinary income3,361million yenYear on year +90.1%Progress 32.0%
Net income attributable to owners of the parent2,230million yenYear on year +124.9%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥30.05
Financial position at period-end
Total assets203,359million yen
of which net assets 96,246 million yenEquity ratio 47.0%vs. prior year-end -1.5pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Segment revenueVision Care Business 30,211 million yen (YoY +7.1%), Other 2,165 million yen (YoY +6.5%)
Segment profitVision Care Business 5,187 million yen (YoY +42.7%), Other -146 million yen
Outlook and shareholder returns
Full-year earnings forecast
Net Sales133,000 million yen (YoY +5.9%)
Operating profit11,000 million yen (YoY +7.5%)
Ordinary income10,500 million yen (YoY -4.7%)
Profit attributable to owners of the parent6,500 million yen (YoY +9.9%)
Annual Dividend Forecast28 yen and sen → 28 yen and sen(0.0%)
Factors Behind Changes in Business Performance

Net sales increased due to higher sales of daily disposable contact lenses in Japan and overseas and higher MELS Plan revenue. Operating profit increased due to higher gross profit accompanying the rise in net sales and a review of the cost structure for selling, general and administrative expenses. Ordinary profit increased because the Company shifted from a foreign exchange loss in the same period of the previous year to a foreign exchange gain.

Disclosure regarding the going concern assumption

No applicable matters.

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 1 / Company name 株式会社インターオプチカル / Excluded Number of companies 1 / Company name 美尼旺(上海)寵物保健有限公司
Impairment lossNo applicable matters.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets 0 million yen, Gain on reversal of foreign currency translation adjustment 1 million yen / Extraordinary loss Loss on sale of fixed assets 0 million yen, Loss on Disposal of Fixed Assets 4 million yen
Depreciation and amortization2,447 million yen
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End76,771,488
Treasury Shares at Period-End2,515,524
Results for this period
ItemDetails
Fiscal Period ClassificationFirst quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 April 2026 to 30 June 2026
Net Sales32,376 million yen (YoY +7.0%)
Operating profit3,429 million yen (YoY +74.9%)
Ordinary income3,361 million yen (YoY +90.1%)
Profit attributable to owners of the parent2,230 million yen (YoY +124.9%)
Net income per share¥30.05
Equity ratioEnd of the current fiscal period 47 / End of previous period 48.5
Total assets203,359 million yen
Net assets96,246 million yen
Full-year earnings forecastNet Sales 133,000 million yen (YoY +5.9%) / Operating profit 11,000 million yen (YoY +7.5%) / Ordinary income 10,500 million yen (YoY -4.7%) / Profit attributable to owners of the parent 6,500 million yen (YoY +9.9%)
Annual Dividend Forecast28 yen and sen → 28 yen and sen(0.0%)
Segment revenueVision Care Business 30,211 million yen (YoY +7.1%), Other 2,165 million yen (YoY +6.5%)
Segment profitVision Care Business 5,187 million yen (YoY +42.7%), Other -146 million yen
Depreciation and amortization2,447 million yen
Impairment lossNo applicable matters.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets 0 million yen, Gain on reversal of foreign currency translation adjustment 1 million yen / Extraordinary loss Loss on sale of fixed assets 0 million yen, Loss on Disposal of Fixed Assets 4 million yen
Disclosure regarding the going concern assumptionNo applicable matters.
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew Number of companies 1 / Company name 株式会社インターオプチカル / Excluded Number of companies 1 / Company name 美尼旺(上海)寵物保健有限公司
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End76,771,488
Treasury Shares at Period-End2,515,524
Factors Behind Changes in Business PerformanceNet sales increased due to higher sales of daily disposable contact lenses in Japan and overseas and higher MELS Plan revenue. Operating profit increased due to higher gross profit accompanying the rise in net sales and a review of the cost structure for selling, general and administrative expenses. Ordinary profit increased because the Company shifted from a foreign exchange loss in the same period of the previous year to a foreign exchange gain.
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Higher sales of daily disposable contact lenses in Japan and overseas and higher MELS Plan revenue, an increase in gross profit accompanying the rise in net sales, a review of the cost structure for selling, general and administrative expenses, and a shift from a foreign exchange loss in the same period of the previous year to a foreign exchange gain.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated) | Menicon Co.,Ltd. (7780) timely disclosure | Komori